Central nervous system destruction mediated by glutamic acid decarboxylase-specific CD4+ T cells

Journal of Immunology

Volumn 184, Issue 9, 2010, Pages 4863-4870

  Burton, Amanda R ^a   Baquet, Zachary ^a,d   Eisenbarth, George S ^b   Tisch, Roland ^c   Smeyne, Richard ^a   Workman, Creg J ^a   Vignali, Dario A A ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF COLORADO DENVER   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d UNITED STATES AGENCY FOR INTERNATIONAL DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; EPITOPE HEL[11-25]; GAMMA INTERFERON; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 65; GLUTAMATE DECARBOXYLASE 65 ANTIBODY; GLUTAMATE DECARBOXYLASE ANTIBODY; GLUTAMATE DECARBOXYLASE[221-237]; GLUTAMATE DECARBOXYLASE[284-300]; UNCLASSIFIED DRUG; AUTACOID; AUTOANTIBODY; CYTOKINE; GLUTAMATE DECARBOXYLASE 2; LYMPHOCYTE ANTIGEN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; BLOOD BRAIN BARRIER; BRAIN; CD4+ T LYMPHOCYTE; CELL ISOLATION; CELL SPECIFICITY; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; ENCEPHALOMYELITIS; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNOPATHOGENESIS; IMMUNOREACTIVITY; INCIDENCE; MEDIATOR; MICROGLIA; MOUSE; NONHUMAN; PARENCHYMA; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; ANIMAL; BIOSYNTHESIS; CELL CLONE; CELL MOTION; ENZYMOLOGY; GENETICS; IMMUNOLOGY; IMMUNOPHENOTYPING; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE MUTANT; NONOBESE DIABETIC MOUSE; PATHOLOGY; PHYSIOLOGY; SECRETION; TRANSGENIC MOUSE;

ANIMALS; AUTOANTIBODIES; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; CLONE CELLS; CYTOKINES; DIABETES MELLITUS, TYPE 1; ENCEPHALOMYELITIS; EPITOPES, T-LYMPHOCYTE; FEMALE; GLUTAMATE DECARBOXYLASE; IMMUNOPHENOTYPING; INFLAMMATION MEDIATORS; MICE; MICE, INBRED NOD; MICE, KNOCKOUT; MICE, SCID; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL;

EID: 77954508238     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0903728     Document Type: Article

References (32)

1. Kaufman, D. L., M. Clare-Salzler, J. Tian, T. Forsthuber, G. S. Ting, P. Robinson, M. A. Atkinson, E. E. Sercarz, A. J. Tobin, and P. V. Lehmann. 1993. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366: 69-72.
2. Tisch, R., X. D. Yang, S. M. Singer, R. S. Liblau, L. Fugger, and H. O. McDevitt. 1993. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 366: 72-75.
3. Solimena, M., F. Folli, R. Aparisi, G. Pozza, and P. De Camilli. 1990. Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome. N. Engl. J. Med. 322: 1555-1560.
4. Solimena, M., F. Folli, S. Denis-Donini, G. C. Comi, G. Pozza, P. De Camilli, and A. M. Vicari. 1988. Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus. N. Engl. J. Med. 318: 1012-1020.
5. Baekkeskov, S., H. J. Aanstoot, S. Christgau, A. Reetz, M. Solimena, M. Cascalho, F. Folli, H. Richter-Olesen, P. De Camilli, and P. D. Camilli. 1990. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347: 151-156.
6. Ishida, K., H. Mitoma, S. Y. Song, T. Uchihara, A. Inaba, S. Eguchi, T. Kobayashi, and H. Mizusawa. 1999. Selective suppression of cerebellar GABAergic transmission by an autoantibody to glutamic acid decarboxylase. Ann. Neurol. 46: 263-267.
7. Dinkel, K., H. M. Meinck, K. M. Jury, W. Karges, and W. Richter. 1998. Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome. Ann. Neurol. 44: 194-201.
8. Arnold, P. Y., A. R. Burton, and D. A. Vignali. 2004. Diabetes incidence is unaltered in glutamate decarboxylase 65-specific TCR retrogenic nonobese diabetic mice: generation by retroviral-mediated stem cell gene transfer. J. Immunol. 173: 3103-3111.
9. Burton, A. R., E. Vincent, P. Y. Arnold, G. P. Lennon, M. Smeltzer, C. S. Li, K. Haskins, J. Hutton, R. M. Tisch, E. E. Sercarz, et al. 2008. On the pathogenicity of autoantigen-specific T-cell receptors. Diabetes 57: 1321-1330.
10. Tisch, R., B. Wang, M. A. Atkinson, D. V. Serreze, and R. Friedline. 2001. A glutamic acid decarboxylase 65-specific Th2 cell clone immunoregulates autoimmune diabetes in nonobese diabetic mice. J. Immunol. 166: 6925-6936.
11. Holst, J., A. L. Szymczak-Workman, K. M. Vignali, A. R. Burton, C. J. Workman, and D. A. Vignali. 2006. Generation of T-cell receptor retrogenicmice. Nat. Protoc. 1: 406-417.
12. Holst, J., K. M. Vignali, A. R. Burton, and D. A. Vignali. 2006. Rapid analysis of T-cell selection in vivo using T cell-receptor retrogenic mice. Nat. Methods 3: 191-197.
13. Szymczak, A. L., and D. A. Vignali. 2005. Development of 2A peptide-based strategies in the design of multicistronic vectors. Expert Opin. Biol. Ther. 5: 627-638.
14. Szymczak, A. L., C. J. Workman, Y. Wang, K. M. Vignali, S. Dilioglou, E. F. Vanin, and D. A. Vignali. 2004. Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vector. Nat. Biotechnol. 22: 589-594.
15. Jaeckel, E., L. Klein, N. Martin-Orozco, and H. von Boehmer. 2003. Normal incidence of diabetes in NOD mice tolerant to glutamic acid decarboxylase. J. Exp. Med. 197: 1635-1644.
16. Yu, L., M. Rewers, R. Gianani, E. Kawasaki, Y. Zhang, C. Verge, P. Chase, G. Klingensmith, H. Erlich, J. Norris, and G. S. Eisenbarth. 1996. Antiislet autoantibodies usually develop sequentially rather than simultaneously. J. Clin. Endocrinol. Metab. 81: 4264-4267.
17. Yu, L., D. T. Robles, N. Abiru, P. Kaur, M. Rewers, K. Kelemen, and G. S. Eisenbarth. 2000. Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes. Proc. Natl. Acad. Sci. U.S.A. 97: 1701-1706.
18. Lennon, G. P., M. Bettini, A. R. Burton, E. Vincent, P. Y. Arnold, P. Santamaria, and D. A. Vignali. 2009. T cell islet accumulation in type 1 diabetes is a tightly regulated, cell-autonomous event. Immunity 31: 643-653.
19. Duvernoy, H. M., and P. Y. Risold. 2007. The circumventricular organs: an atlas of comparative anatomy and vascularization. Brain Res. Rev. 56: 119-147.
20. Fry, M., and A. V. Ferguson. 2007. The sensory circumventricular organs: brain targets for circulating signals controlling ingestive behavior. Physiol. Behav. 91: 413-423.
21. Makinae, K., T. Kobayashi, T. Kobayashi, H. Shinkawa, H. Sakagami, H. Kondo, F. Tashiro, J. Miyazaki, K. Obata, S. Tamura, and Y. Yanagawa. 2000. Structure of the mouse glutamate decarboxylase 65 gene and its promoter: preferential expression of its promoter in the GABAergic neurons of transgenic mice. J. Neurochem. 75: 1429-1437.
22. Imai, Y., and S. Kohsaka. 2002. Intracellular signaling in M-CSF-induced microglia activation: role of Iba1. Glia 40: 164-174.
23. Li, L., B. Wang, J. A. Frelinger, and R. Tisch. 2008. T-cell promiscuity in autoimmune diabetes. Diabetes 57: 2099-2106.
24. Brown, P., and C. D. Marsden. 1999. The stiff man and stiff man plus syndromes. J. Neurol. 246: 648-652.
25. Skorstad, G., A. L. Hestvik, F. Vartdal, and T. Holmøy. 2009. Cerebrospinal fluid T cell responses against glutamic acid decarboxylase 65 in patients with stiff person syndrome. J. Autoimmun. 32: 24-32.
26. Costa, M., A. Saiz, R. Casamitjana, M. F. Castañer, A. Sanmartí, F. Graus, and D. Jaraquemada. 2002. T-cell reactivity to glutamic acid decarboxylase in stiffman syndrome and cerebellar ataxia associated with polyendocrine autoimmunity. Clin. Exp. Immunol. 129: 471-478.
27. Hummel, M., I. Durinovic-Bello, E. Bonifacio, V. Lampasona, J. Endl, S. Fessele, F. Then Bergh, C. Trenkwalder, E. Standl, and A. G. Ziegler. 1998. Humoral and cellular immune parameters before and during immunosuppressive therapy of a patient with stiff-man syndrome and insulin dependent diabetes mellitus. J. Neurol. Neurosurg. Psychiatry 65: 204-208.
28. Schloot, N. C., M. C. Batstra, G. Duinkerken, R. R. De Vries, T. Dyrberg, A. Chaudhuri, P. O. Behan, and B. O. Roep. 1999. GAD65-Reactive T cells in a nondiabetic stiff-man syndrome patient. J. Autoimmun. 12: 289-296.
29. Warren, J. D., G. Scott, P. C. Blumbergs, and P. D. Thompson. 2002. Pathological evidence of encephalomyelitis in the stiff man syndrome with anti-GAD antibodies. J. Clin. Neurosci. 9: 328-329.
30. Mitsumoto, H., M. J. Schwartzman, M. L. Estes, S. M. Chou, E. F. La Franchise, P. De Camilli, and M. Solimena. 1991. Sudden death and paroxysmal autonomic dysfunction in stiff-man syndrome. J. Neurol. 238: 91-96.
31. Ludvigsson, J., M. Faresjö, M. Hjorth, S. Axelsson, M. Chéramy, M. Pihl, O. Vaarala, G. Forsander, S. Ivarsson, C. Johansson, et al. 2008. GAD treatment and insulin secretion in recent-onset type 1 diabetes. N. Engl. J. Med. 359: 1909-1920.
32. Winer, S., I. Astsaturov, R. Cheung, L. Gunaratnam, V. Kubiak, M. A. Cortez, M. Moscarello, P. W. O'Connor, C. McKerlie, D. J. Becker, and H. M. Dosch. 2001. Type I diabetes and multiple sclerosis patients target islet plus central nervous system autoantigens; nonimmunized nonobese diabetic mice can develop autoimmune encephalitis. J. Immunol. 166: 2831-2841.